[Federal Register Volume 78, Number 99 (Wednesday, May 22, 2013)]
[Notices]
[Page 30270]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-12214]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-46-2013]


Foreign-Trade Zone (FTZ) 61--San Juan, Puerto Rico, Notification 
of Proposed Production Activity, Janssen Ortho LLC (Pharmaceutical 
Products Production), Gurabo, Puerto Rico

    The Puerto Rico Trade and Export Company, grantee of FTZ 61, 
submitted a notification of proposed production activity to the FTZ 
Board on behalf of Janssen Ortho LLC (Janssen), located in Gurabo, 
Puerto Rico. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on April 29, 
2013.
    A separate application for subzone status at the Janssen facility 
was submitted and will be processed under Section 400.31 of the FTZ 
Board's regulations. The facility is used for the production of various 
prescription and over-the-counter pharmaceutical products. Pursuant to 
15 CFR 400.14(b), FTZ activity would be limited to the specific 
foreign-status materials and components and specific finished products 
listed in the submitted notification (as described below) and 
subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Janssen from customs 
duty payments on the foreign status components used in export 
production. On its domestic sales, Janssen would be able to choose the 
duty rates during customs entry procedures that apply to various 
prescription and over-the-counter pharmaceutical products, including: 
Anti-cancer; anti-diabetic and immunosuppressive medicaments; 
analgesics; antipyretic and anti-inflammatory agents; and, cough and 
cold preparations (duty free) for the foreign status inputs noted 
below. Customs duties also could possibly be deferred or reduced on 
foreign status production equipment.
    The components and materials sourced from abroad include: Splenda 
sucralose; cobicistate silicon dioxide; metformin; canagliflozin; and 
darunavir ethanolate API (duty rates range from 86.2 cents/kg to 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary at the 
address below. The closing period for their receipt is July 1, 2013.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.

FOR FURTHER INFORMATION CONTACT: Diane Finver at [email protected] 
or (202) 482-1367.

    Dated: May 16, 2013.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2013-12214 Filed 5-21-13; 8:45 am]
BILLING CODE 3510-DS-P